文献速递瓣膜外科

经导管与外科主动脉瓣置换十年结局:OBSERVANT研究延长随访

Ten-Year Outcomes of Transcatheter versus Surgical Aortic Valve Replacement: Extended Follow-up from the OBSERVANT Study.
PubMed 文献 · Eur J Cardiothorac Surg · 2026-01-01

基于意大利多中心OBSERVANT研究,采用倾向评分匹配比较SAVR与经股动脉TAVR患者10年结局。匹配650对患者后,TAVR全因死亡(HR 1.39,95%CI 1.22-1.59;P<.001)和MACCE(HR 1.33,95%CI 1.18-1.51;P<.001)风险显著高于SAVR,但再次主动脉干预风险显著更低(SHR 0.33,95%CI 0.12-0.91;P=.024)。

要点

  • 匹配后10年TAVR全因死亡风险显著高于SAVR(HR 1.39)。
  • TAVR的MACCE风险亦显著高于SAVR(HR 1.33)。
  • TAVR再次主动脉干预风险显著低于SAVR(SHR 0.33)。

核心结论

  • 在意大利临床实践中,早期代TAVR 10年全因死亡和MACCE风险显著高于SAVR,但再次主动脉干预风险显著更低。

研究设计与样本

  • 多中心观察性研究OBSERVANT的延长随访,纳入2010年12月至2012年6月间5707例SAVR和1911例TAVR患者,经倾向评分匹配后分析650对患者。

主要发现

  • 10年时TF-TAVR全因死亡风险高于SAVR(HR 1.39,95%CI 1.22-1.59;P<.001)。
  • 10年时TF-TAVR的MACCE风险高于SAVR(HR 1.33,95%CI 1.18-1.51;P<.001)。
  • 心衰再住院(P=.443)、心脏原因再住院(P=.552)和脑血管事件(P=.573)两组无显著差异。
  • TAVR再次主动脉干预风险显著低于SAVR(SHR 0.33,95%CI 0.12-0.91;P=.024)。

临床怎么用

  • 解读长期结局时需注意本研究反映的是早期代TAVR器械,不能直接外推至当代TAVR。

局限性

  • 研究使用早期代TAVR器械,结果可能不适用于当前临床实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compare long-term clinical outcomes of patients undergoing surgical (SAVR) or transcatheter aortic valve replacement (TAVR) in the Italian clinical practice and enrolled in the multicentre OBSERVANT (Observational Study of Effectiveness of SAVR-TAVI Procedures for Severe Aortic Stenosis Treatment) Study. METHODS: Propensity score matching was used to compare patients undergoing SAVR or transfemoral (TF) TAVR with similar baseline characteristics. The primary end points were all-cause mortality and major adverse cardiac and cerebrovascular events (MACCE) at 10 years. Prespecified secondary end points included cerebrovascular accidents, repeat aortic intervention, repeat hospitalization due to cardiac reasons and heart failure. All outcomes were adjudicated through a linkage with administrative databases. RESULTS: From the entire cohort (n = 5707 SAVR and n = 1911 TAVR treated between December 2010 and June 2012), 650 matched pairs of patients were considered. At 10 years, TF-TAVR was associated with a higher risk of all-cause mortality (Hazard ratio [HR] 1.39, 95% confidence interval [CI] 1.22-1.59; P < .001) and MACCE (HR 1.33, 95% CI 1.18-1.51; P < .001) compared to SAVR. Secondary end-points did not differ for rehospitalization for heart failure (P = .443) or cardiac reasons (P = .552), and for cerebrovascular events (P = .573), but TAVR had a significantly lower risk of repeat aortic intervention (Sub-distributional HR [SHR], 0.33; 95% CI, 0.12-0.91; P = .024] at 10 years. CONCLUSIONS: At 10 years, early generation TAVR had a significantly higher risk of all-cause mortality and MACCE, but a lower risk of repeat aortic intervention in clinical practice.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Costa G, Barbanti M, Rosato S, et al. Ten-Year Outcomes of Transcatheter versus Surgical Aortic Valve Replacement: Extended Follow-up from the OBSERVANT Study. Eur J Cardiothorac Surg. 2026. PMID: 41460190. doi:10.1093/ejcts/ezaf476

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。